Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community

Journal of the American College of Surgeons

Volumn 196, Issue 2, 2003, Pages 180-188

  Oluwole, Soji F ^a,b   Ali, Ayoola O ^a   Adu, Albert ^a   Blane, Brenda P ^a   Barlow, Barbara ^a   Oropeza, Ruben ^a   Freeman, Harold P ^a  

^a Coll Phys/Surg of Columbia Univ ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MEDICAL SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RACE DIFFERENCE; URBAN POPULATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MASS SCREENING; MEDICALLY UNDERSERVED AREA; MEDICALLY UNINSURED; MIDDLE AGED; NEOPLASM STAGING; NEW YORK CITY; OUTPATIENT CLINICS, HOSPITAL; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; URBAN POPULATION;

EID: 0037324593     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01765-9     Document Type: Article

References (40)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. CA Cancer J Clin 2002;52:23-47.
2. Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients 1960-1973. J Natl Cancer Inst 1984;73:341-352.
3. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women, CA Cancer J Clin 2000;50:50-64.
4. Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer 1989;63:2562-2569.
5. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 1995;3:19-30.
6. Ries LAG, Kosary CL, Hankey BF, et al, eds. Surveillance, epidemiology, and end results (SEER) cancer statistics review 1973-1996. Bethesda, MD: National Cancer Institute; 1999.
7. Bland KI, Menck HR, Scott-Conner CEH, et al. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-1273.
8. Joslyn SA, West MM. Racial differences in breast carcinoma survival. Cancer 2000;88:114-123.
9. Edwards MJ, Gamel JW, Vaughan WP, Wrightson WR. Infiltrating ductal carcinoma of the breast: the survival impact of race. J Clin Oncol 1998; 16:2693-2699.
10. Surveillance, epidemiology, and end results (SEER) cancer statistics review 1973-1997. Bethesda, MD: National Cancer Institute; 2000.
11. Newman LA, Carolin K, Simon M, et al. Impact of breast carcinoma on African-American women. Cancer 2001;91:1834-1843.
12. Bibb SC. The relationship between access and stage at diagnosis of breast cancer in African-American and Caucasian women. Oncol Nurs Forum 2001;28:711-719.
13. Menck HR, Mills PK. The influence of urbanization, age, ethnicity, and income on the early diagnosis of breast carcinoma: opportunity for screening improvement. Cancer 2001;92: 1299-1304.
14. Furberg H, Millikan R, Dressler L, et al. Tumor characteristics in African-American and white women. Breast Cancer Res Treat 2001;68:33-43.
15. Muss HB. Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status. J Natl Cancer Inst Monogr 2001;2001:52-55.
16. Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer 1996;77: 308-314.
17. Oluwole SF, Fadiran OA, Odesanmi WO. Diseases of the breast in Nigeria. Br J Surg 1987;74:582-585.
18. Miller BA, Kolonel LN, Bernstein L, et al. Racial/ethnic patterns of cancer in the United States 1988-1992. Bethesda, MD: National Cancer Institute; 1996.
19. Swanson GM, Lin CS. Survival patterns among younger women with breast cancer: the effects of age, race, state, and treatment. J Natl Cancer Inst 1994; 16:69-77.
20. Chen VW, Correa P, Kurman RJ, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 1994;3:127-135.
21. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 1994;86:705-712.
22. Kurtz JM, Spitalier JM, Amalric R, et al. Mammary recurrences in women younger than forty. Int J Radiat Oncol Phys 1988;15: 271-276.
23. Kim SH, Simkovich-Heerdt A, Tran KN, et al. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg 1998; 187:1-8.
24. Ferguson CM, Powell RW. Breast masses in young women. Arch Surg 1989;124:1338-1341.
25. Mitra N, Schnabel FR, Neugut AI, Heitjan DF. Estimating the effect of an intensive surveillance program on state of breast carcinoma at diagnosis: a propensity score analysis. Cancer 2001;91:1709-1715.
26. Yood MU, Johnson CC, Blount A, et al. Race and differences in breast cancer survival in a managed care program. J Natl Cancer Inst 1999;91:1487-1491.
27. Winchester DP, Menck HR, Osteen RI, Kraybill W. Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol 1995;2:207-213.
28. Heimann R, Ferguson D, Powers C, et al. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol 1997;15:2329-2337.
29. Tabar L, Vitak B, Chen HT, et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91:1724-1731.
30. Cady B, Michaelson JS. The life-sparing potential of mammographic screening. Cancer 2001;91:1699-1703.
31. Kopans DB. Updated results of the trials of screening mammography. Surg Oncol Clin North Am 1997;6:233-263.
32. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134.
33. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-1342.
34. , Wald N. Populist instead of professional. J Med Screen 2000; 7:1.
35. Duffy SW. Interpretation of the breast screening trials: a commentary on the recent paper by Gotzsche and Olsen. Breast 2001;10:209-212.
36. Lee JH, Zuckerman D. Screening for breast cancer with mammography. Lancet 2001; 358:2164-2168.
37. Winchester DP. Jeske JM, Goldschmidt RA. The diagnosis and management of ductal carcinoma in-situ of the breast. CA Cancer J Clin 2000; 184-200.
38. Winchester DP, Cox JD. Standards for breast-conservation treatment. CA Cancer J Clin 1992;42:134-176.
39. Cady B. New era in breast cancer: impact of screening on disease presentation. Surg Oncol Clin N Am 1997;6:195-202.
40. Michaelson J, Satija S, Moore R, et al. The pattern of breast cancer screening utilization and its consequences. Cancer 2002; 94:37-43.